Viewing nowCombinationCandelova Tablet 5/8 mg
Rosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.

MFDS item code 202008711 · Approved 2020.12.11
Improvement of hypertension and heart failure, and inhibition of hyperlipidemia and cardiovascular disease risk
This medication is developed for patients who need to take Candesartan Cilexetil and Rosuvastatin together. Candesartan Cilexetil is used in patients with essential hypertension or heart failure with left ventricular systolic dysfunction when additional treatment beyond ACE inhibitors is needed or if they are intolerant to such treatment. Rosuvastatin is used as an adjunct in the treatment of hyperlipidemia, especially when not controlled by diet and exercise, and helps to slow the progression of atherosclerosis and reduce the risk of cardiovascular disease. Furthermore, it helps reduce the risk of stroke, myocardial infarction, and vascular reintervention in patients at high risk for cardiovascular diseases. Therefore, this medication is used to manage cholesterol levels in the blood while controlling blood pressure, improving cardiovascular health.
For the treatment of essential hypertension with Candesartan Cilexetil, an initial and maintenance dose of 8-16 mg orally once daily is recommended. If blood pressure control is insufficient, the dose can be increased to a maximum of 32 mg once daily. For heart failure treatment, the initial dose is 4 mg once daily, and the dose can be doubled at intervals of more than 2 weeks, to a maximum of 32 mg once daily. The initial dose of Rosuvastatin is 1
The safety and efficacy in adolescents and children under 18 years have not been established.
This medication can cause serious harm to the fetus and newborn during pregnancy, so it must be discontinued immediately once pregnancy is confirmed. Patients with an allergy to this medication or its components, liver disease, severe hepatic impairment, severe renal failure, hereditary angioedema, pregnant or breastfeeding women, and those with myopathy should not take this medication. Elderly patients and those with hyperkalemia, liver dysfunction, cardiac diseases, renal dysfunction should use this medication with greater caution, and renal function and potassium levels should be routinely monitored through blood tests. This medication can cause myalgia or muscle weakness, and in rare cases, severe muscle damage (rhabdomyolysis), so if unexplained muscle pain or weakness occurs during treatment, a physician should be consulted immediately. Regular liver function tests are crucial for assessing the impact on liver function before and during treatment. Care should be taken when taking this medication with other drugs, particularly potassium-sparing diuretics, certain antibiotics, antifungals, immunosuppressants, and fibrate agents, as interactions may occur. Women who might become pregnant should use adequate contraception, and this medication should not be taken during pregnancy or lactation. In cases of overdose, symptoms such as hypotension, dizziness, and tachycardia may occur, so immediate medical attention is required. There is no specific antidote, and treatment will be symptom-based. During treatment, temporary dizziness or fatigue due to blood pressure-lowering effects may occur, so caution should be exercised when driving or operating machinery. Keep this medication out of reach of children, and it is safer not to transfer the medication from its original container to another.
Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, mucosal pain in mouth/eyes, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough + fever, jaundice (yellowing of skin or eyes), profound lethargy, sudden and severe headaches, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis,
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture ingress, and it should be kept at room temperature between 1°C and 30°C. Proper storage will help maintain the effectiveness of the medication.
Pink round film-coated tablet
30 tablets (10 tablets per PTP X 3) - 30 tablets/PTP [30 tablets (10 tablets/PTP X 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
AlboGen Korea Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Candesartan Cilexetil 32mg
Tablet · Prescription medication · Combination
Albogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.